pirfenidone has been researched along with Left Ventricular Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Li, H; Wang, Y; Wu, Y; Zhao, S | 1 |
| Brown, L; Fenning, A; Margolin, SB; Mirkovic, S; Seymour, AM; Strachan, A; Taylor, SM | 1 |
2 other study(ies) available for pirfenidone and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Pirfenidone attenuates cardiac fibrosis in a mouse model of TAC-induced left ventricular remodeling by suppressing NLRP3 inflammasome formation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrier Proteins; Collagen; Constriction; Fibrosis; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Interleukin-1beta; Male; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Myocytes, Cardiac; Myofibroblasts; NLR Family, Pyrin Domain-Containing 3 Protein; Pyridones; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Survival Rate; Transforming Growth Factor beta1; Ventricular Remodeling | 2013 |
Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats.
Topics: Amiloride; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta, Thoracic; Biological Availability; Collagen; Desoxycorticosterone; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Myocardium; Norepinephrine; Pyridones; Rats; Rats, Wistar; Sodium Chloride, Dietary; Vasoconstrictor Agents | 2002 |